1. Home
  2. APLM vs TAIT Comparison

APLM vs TAIT Comparison

Compare APLM & TAIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLM
  • TAIT
  • Stock Information
  • Founded
  • APLM 2016
  • TAIT 1989
  • Country
  • APLM United States
  • TAIT United States
  • Employees
  • APLM N/A
  • TAIT N/A
  • Industry
  • APLM Blank Checks
  • TAIT Electronic Components
  • Sector
  • APLM Finance
  • TAIT Technology
  • Exchange
  • APLM Nasdaq
  • TAIT Nasdaq
  • Market Cap
  • APLM 15.6M
  • TAIT 17.2M
  • IPO Year
  • APLM N/A
  • TAIT 1995
  • Fundamental
  • Price
  • APLM $0.10
  • TAIT $2.90
  • Analyst Decision
  • APLM Strong Buy
  • TAIT
  • Analyst Count
  • APLM 2
  • TAIT 0
  • Target Price
  • APLM $4.25
  • TAIT N/A
  • AVG Volume (30 Days)
  • APLM 1.2M
  • TAIT 10.8K
  • Earning Date
  • APLM 08-14-2024
  • TAIT 11-19-2024
  • Dividend Yield
  • APLM N/A
  • TAIT 6.89%
  • EPS Growth
  • APLM N/A
  • TAIT N/A
  • EPS
  • APLM N/A
  • TAIT 0.25
  • Revenue
  • APLM $2,101,000.00
  • TAIT $4,719,000.00
  • Revenue This Year
  • APLM N/A
  • TAIT N/A
  • Revenue Next Year
  • APLM N/A
  • TAIT N/A
  • P/E Ratio
  • APLM N/A
  • TAIT $11.31
  • Revenue Growth
  • APLM 70.54
  • TAIT N/A
  • 52 Week Low
  • APLM $0.10
  • TAIT $2.57
  • 52 Week High
  • APLM $1.79
  • TAIT $3.61
  • Technical
  • Relative Strength Index (RSI)
  • APLM 34.54
  • TAIT 56.12
  • Support Level
  • APLM $0.11
  • TAIT $2.81
  • Resistance Level
  • APLM $0.13
  • TAIT $3.05
  • Average True Range (ATR)
  • APLM 0.01
  • TAIT 0.09
  • MACD
  • APLM -0.00
  • TAIT 0.01
  • Stochastic Oscillator
  • APLM 4.02
  • TAIT 40.52

About APLM Apollomics Inc.

Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

About TAIT Taitron Components Incorporated

Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.

Share on Social Networks: